WO2011034514A3 - Stable micronized granules having high solubility - Google Patents

Stable micronized granules having high solubility Download PDF

Info

Publication number
WO2011034514A3
WO2011034514A3 PCT/TR2010/000181 TR2010000181W WO2011034514A3 WO 2011034514 A3 WO2011034514 A3 WO 2011034514A3 TR 2010000181 W TR2010000181 W TR 2010000181W WO 2011034514 A3 WO2011034514 A3 WO 2011034514A3
Authority
WO
WIPO (PCT)
Prior art keywords
high solubility
stable micronized
micronized granules
granules
stable
Prior art date
Application number
PCT/TR2010/000181
Other languages
French (fr)
Other versions
WO2011034514A2 (en
Inventor
Bilgic Mahmut
Original Assignee
Bilgic Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bilgic Mahmut filed Critical Bilgic Mahmut
Publication of WO2011034514A2 publication Critical patent/WO2011034514A2/en
Publication of WO2011034514A3 publication Critical patent/WO2011034514A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Abstract

The present invention relates to moxifloxacin composition with improved solubility and stability, preparation method of these compositions and medical use.
PCT/TR2010/000181 2009-09-18 2010-09-06 Stable micronized granules having high solubility WO2011034514A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2009/07227A TR200907227A2 (en) 2009-09-18 2009-09-18 Stable micronized granules with high solubility.
TR2009/07227 2009-09-18

Publications (2)

Publication Number Publication Date
WO2011034514A2 WO2011034514A2 (en) 2011-03-24
WO2011034514A3 true WO2011034514A3 (en) 2011-11-10

Family

ID=43759215

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2010/000181 WO2011034514A2 (en) 2009-09-18 2010-09-06 Stable micronized granules having high solubility

Country Status (2)

Country Link
TR (1) TR200907227A2 (en)
WO (1) WO2011034514A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1106900A2 (en) * 2011-12-26 2013-11-05 Ems Sa SOLID PHARMACEUTICAL COMPOSITION UNDERSTANDING ANTIBOTH FAMILY OF QUINOLONES AND THE PROCESS OF OBTAINING THEM
GR1008169B (en) * 2013-03-19 2014-04-08 "Φαρματεν Α.Β.Ε.Ε.", Pharmaceutical composition comprising a fluoroquinolone antibacterial agent and method for the preparation thereof
JP7074963B2 (en) 2017-01-31 2022-05-25 ヴェル インコーポレイテッド Compositions and Methods for Long-term Release of Gonadotropin-Releasing Hormone (GnRH) Antagonists

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000027398A1 (en) * 1998-11-10 2000-05-18 Bayer Aktiengesellschaft Pharmaceutical moxifloxacin preparation
WO2009135646A2 (en) * 2008-05-05 2009-11-12 Farmaprojects, Sa Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
WO2010041100A1 (en) * 2008-10-09 2010-04-15 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Using of organic solvents in wet granulation of moxifloxacin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000027398A1 (en) * 1998-11-10 2000-05-18 Bayer Aktiengesellschaft Pharmaceutical moxifloxacin preparation
WO2009135646A2 (en) * 2008-05-05 2009-11-12 Farmaprojects, Sa Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
WO2010041100A1 (en) * 2008-10-09 2010-04-15 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Using of organic solvents in wet granulation of moxifloxacin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BOWEN P: "Particle Size Distribution Measurement from Millimeters to Nanometers and from Rods to Platelets", JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, TAYLOR AND FRANCIS GROUP, NEW YORK, NY, US, vol. 23, no. 5, 1 January 2002 (2002-01-01), pages 631 - 662, XP009102859, ISSN: 0193-2691, DOI: 10.1081/DIS-120015368 *

Also Published As

Publication number Publication date
TR200907227A2 (en) 2011-04-21
WO2011034514A2 (en) 2011-03-24

Similar Documents

Publication Publication Date Title
WO2012021715A3 (en) Stable formulations of linaclotide
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
WO2012112410A3 (en) Micronized placental tissue compositions and methods for making and using the same
WO2012042371A3 (en) Pharmaceutical composition
WO2011153157A3 (en) Benzoquinolone inhibitors of vmat2
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
IL224288A (en) Derivatives of substituted pyrazolamide, pharmaceutical compositions comprising the same and uses thereof
WO2008132229A3 (en) Highly concentrated insulin solutions and compositions
HK1164050A1 (en) Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
WO2012088038A3 (en) Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
WO2011098582A3 (en) Novel crystalline forms of ivabradine hydrochloride
WO2010114405A3 (en) Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
MX2011014019A (en) Diazahomoadamantane derivatives and methods of use thereof.
PL2768936T3 (en) Formulations, their use as or for the manufacture of dishwashing compositions, and manufacture
WO2012088124A3 (en) Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
WO2014086982A3 (en) Stable metal compounds, their compositions and methods of their use
IL208613A (en) Azetidine derivatives, methods of their preparation, compositions comprising them and uses thereof
WO2012049307A3 (en) Novel n-terminally modified insulin derivatives
WO2012037562A3 (en) Pharmaceutical and nutraceutical compositions of abscisic acid
HK1184181A1 (en) POLYETHERAMINES, COMPOSITIONS INCLUDING POLYETHERAMINES, AND METHODS OF g MAKING
WO2013134534A3 (en) Solid state forms of cabazitaxel and processes for preparation thereof
WO2009115084A3 (en) Pyrrolopyrimidine derivatives, and use thereof
WO2009094457A3 (en) Substituted benzhydrylethers
MX339361B (en) Alternan derivatives.
EP2551266A4 (en) 2',2-dithiazol non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10779863

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 10779863

Country of ref document: EP

Kind code of ref document: A2